Zero concentrations – all samples – full replicate [RSABE / ABEL]

posted by pash413 – India, 2014-04-07 11:30 (4463 d 05:17 ago) – Posting: # 12782
Views: 16,449

Hello HS

❝ I don’t think that you can derive a meaningful comparison from your data.


Agreed to your point.

But the reason behind us being curious to use partial data (subjects with non-zero Cmax/AUC in at-least 2/3 periods) is because one of the firm has used the method of Imputation for same molecule (MESALAMINE) which was well accepted by FDA. (Delzicol Clinical Pharmacology and Bio-pharmaceutics review link provided in my above posts).

We would like to understand the applicability and scope of such statistical methodology.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
349 visitors (0 registered, 349 guests [including 13 identified bots]).
Forum time: 16:47 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5